Skip to main content
. 2012 Dec 21;7:101. doi: 10.1186/1750-1172-7-101

Table 1.

Clinical data of the patients and characteristics of the detected mutations

ID Classification Gender TP53 mutation Effect p53 protein domain function Tumor type (age)
Y1T0
Chompret
F
R213Q CGA>CAA
Missense
DNA binding
Hydathiform mole (23), Ampulla of Vater (41)
Y33T0
LFL Birch
F
V173M GTG>ATG
Missense
DNA binding
Soft tissue sarcoma (23), Breast (43)
Y53T0
Eeles1
F
G245S GGC>AGC
Missense
DNA binding
Bilateral breast (36), Gall bladder (?)
Y57T0
Eeles1
F
G244D GGC>GAC
Missense
DNA binding
Breast (40), Colorectal (?)
Y65T0
Chompret
F
V197M GTG >ATG
Missense
DNA binding
Colorectal (45), Lung (51), Soft tissue sarcoma (51)
Y79T0
Chompret
F
T125T ACG>ACA
Splice
DNA binding
Adrenal carcinoma (1)
Y87T0
LFL/Chompret
M
S241Y TCC>TAC
Missense
DNA binding
Rhabdomyosarcoma (2), Choroid plexus tumor (7), Liposarcoma (10)
Y97T1
LFS
F
IVS8+1G>A
Splice
DNA binding
Breast (27)
Y103T2
LFL/Chompret
F
H214Q
Missense
DNA binding
Breast (62)
Y12T1
LFS
F
R337H CGC>CAC
Missense
Tetramerisation
Soft tissue sarcoma (58), Breast (59), Thyroid (61), Soft tissue sarcoma (62)
Y15T0
Chompret
F
R337H CGC>CAC
Missense
Tetramerisation
Adrenal carcinoma (6), Kidney (7)
Y27T0
LFL Birch
F
R337H CGC>CAC
Missense
Tetramerisation
Breast (36)
Y49T1
Eeles 1
M
R337H CGC>CAC
Missense
Tetramerisation
Kidney (64)
Y99T0
Chompret
F
R337H CGC>CAC
Missense
Tetramerisation
Breast (32)
Y100T0
LFS
F
R337H CGC>CAC
Missense
Tetramerisation
Breast (46)
Y106T0
Chompret
F
R337H CGC>CAC
Missense
Tetramerisation
Breast (43)
Y107T0
LFS
M
R337H CGC>CAC
Missense
Tetramerisation
Adrenal carcinoma (2)
Y127T0
Chompret
M
R337H CGC>CAC
Missense
Tetramerisation
Adrenal carcinoma (3)
Y131T0
LFS
F
R337H CGC>CAC
Missense
Tetramerisation
Leg synovial sarcoma (32)
Y144T0
Chompret
F
R337H CGC>CAC
Missense
Tetramerisation
Breast (29)
Y154T0 Chompret F R337H CGC>CAC Missense Tetramerisation Breast (48)